Announcements Trials
Browse Landscape

Phase

Phase NA 44Phase 3 5Phase 2 4Phase 4 1Phase 1 1

Status

Completed 4Active not recruiting 1

Sponsor Class

OTHER 4FED 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Colorectal Neoplasms 5Adenoma 2Pathologic Complete Response 1Lymphoma, Mantle-Cell 1Anus Neoplasms 1Anal Canal Carcinoma 1Adenomatous Polyps 1Adenoma Detection to Prevent Colorectal Cancer 1

Interventions

Fluorouracil 131Leucovorin 127Oxaliplatin 93Bevacizumab 86Irinotecan 74Capecitabine 63Cetuximab 47Folfox protocol 32Panitumumab 18regorafenib 16trifluridine tipiracil drug combination 15Drug Therapy 14Chemotherapy, Adjuvant 13IFL protocol 10Floxuridine 10Radiotherapy 9Tegafur 7Neoadjuvant Therapy 7Levoleucovorin 7Laparoscopy 7Aspirin 7pembrolizumab 6Trifluridine 6Celecoxib 6atezolizumab 5XELOX 5Mitomycin 5Colonoscopy 5tipiracil 4sintilimab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Colorectal Neoplasms × Colonoscopy × Clear all
NCT00032344 2018-08-31

Long-term Follow-up Study Designed to Evaluate the Relative Risk of Two Colonoscopy Schedules for Patients With Small Polyps

VA Office of Research and Development

Phase 3 Completed
3,200 enrolled
Gastrointestinal

Adenoma, Colorectal Neoplasms

NCT00883792 2017-06-19

NordICC

Oslo University Hospital

Phase 3 Active not recruiting
95,000 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01075633 2014-01-08

COLONFAM

Fundación Canaria Rafael Clavijo para la Investigación Biomédica

Phase 3 Completed
1,501 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01251666 2012-09-03

HeMO

University Hospital, Caen

Phase 3 Completed
19,797 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01399710 2011-07-22

CAD-IMPACT

im3D S.p.A.

Phase 3 Completed
651 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡